Bond Eli Lilly & Company 5.95% ( US532457BC13 ) in USD
Issuer | Eli Lilly & Company |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 5.95% per year ( payment 2 times a year) |
Maturity | 15/11/2037 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 1 000 USD |
Total amount | 400 000 000 USD |
Cusip | 532457BC1 |
Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
Moody's rating | Aa3 ( High grade - Investment-grade ) |
Next Coupon | 15/11/2025 ( In 151 days ) |
Detailed description |
Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products and biologicals. The Bond issued by Eli Lilly & Company ( United States ) , in USD, with the ISIN code US532457BC13, pays a coupon of 5.95% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2037 The Bond issued by Eli Lilly & Company ( United States ) , in USD, with the ISIN code US532457BC13, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Eli Lilly & Company ( United States ) , in USD, with the ISIN code US532457BC13, was rated A+ ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |